Pinnacle Wealth Management Advisory Group, LLC Bridge Bio Pharma, Inc. Transaction History

Pinnacle Wealth Management Advisory Group, LLC

$1.04 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$7.17 - $18.55 $206,137 - $533,312	-28,750 Reduced 66.09%	14,750 $244,000
Q4 2022 Feb 06, 2023	SELL	$6.74 - $11.52 $21,817 - $37,290	-3,237 Reduced 6.93%	43,500 $331,000
Q3 2022 Nov 09, 2022	SELL	$7.94 - $12.36 $42,479 - $66,126	-5,350 Reduced 10.27%	46,737 $465,000
Q4 2021 Jan 20, 2022	SELL	$11.38 - $53.41 $2,276 - $10,682	-200 Reduced 0.38%	52,087 $869,000
Q2 2021 Aug 10, 2021	BUY	$46.47 - $63.93 $2.43 Million - $3.34 Million	52,287 New	52,287 $3.19 Million
Q3 2020 Oct 29, 2020	SELL	$27.2 - $42.19 $1.39 Million - $2.15 Million	-51,044 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$22.22 - $35.69 $1.13 Million - $1.82 Million	51,044 New	51,044 $1.67 Million
Q1 2020 May 08, 2020	SELL	$16.11 - $36.23 $93,438 - $210,133	-5,800 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$17.96 - $46.63 $104,168 - $270,454	5,800 New	5,800 $203,000

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$694 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$691 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$390 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$342 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$167 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Wealth Management Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Wealth Management Advisory Group, LLC with notifications on news.

Account